Document is current
Any future updates will be listed below
-
Authors
Biran, A
Dobson, C
Rees, C
Brooks-Pearson, R
Cunliffe, A
Durrant, L
Hancock, J
Ludlow, H
Neilson, L
Wilson, A
Sharp, L
-
Funding
Funding for this research was provided by:
3-D Matrix (302062)
- License Information
-
More Information
Article History
Received: 9 October 2023
Accepted: 20 December 2023
First Online: 6 January 2024
Declarations
:
: The study received a favourable opinion from the Health and Care Research Wales, research ethics committee on 12th August 2021 (Reference 21/PR/1138).
: Informed consent was provided verbally by participants, immediately prior to interview and was audio recorded.
: The authors affirm that human research participants provided informed consent for publication of pseudonymised verbatim quotes and personal data.
: Biran: Salary, while working on this review, was paid from an unrestricted project grant from 3D-Matrix, held by LS & CR and paid to institution. Rees: Received grant funding from ARC medical, Norgine. Medtronic, 3-D Matrix solutions, and Olympus medical; payments were made to institution. He was an expert witness for ARC medical and Olympus medical. Hancock: Received honoria payments as a speaker for 3-D Matrix presenting my experiences of clinical use of PuraStat. Payments were made to author. Sharp: Received unrestricted project grant funding from 3-D Matrix and Medtronic; payments were made to institution. The remaining authors have no financial or non-financial interests to declare.
